Hepatobiliary transit times of gadoxetate disodium (Primovist ®) for protocol optimization of comprehensive MR imaging of the biliary system - What is normal?

European Journal of Radiology

Volumn 79, Issue 2, 2011, Pages 201-205

  Ringe, Kristina I ^a,b   Husarik, Daniela B ^a   Gupta, Rajan T ^a   Boll, Daniel T ^a   Merkle, Elmar M ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Gd EOB DTPA; Hepatobiliary imaging; MRI; Transit time

Indexed keywords

GADOXETIC ACID;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BODY MASS; COMMON BILE DUCT; CONTRAST ENHANCEMENT; DUODENUM; EXCRETION; FEMALE; GALLBLADDER; HEPATOBILIARY PARAMETERS; HEPATOBILIARY SYSTEM; HEPATOBILIARY TRANSIT TIME; HUMAN; INTESTINE TRANSIT TIME; INTRAHEPATIC BILE DUCT; KIDNEY FUNCTION; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; ODDI SPHINCTER; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEX DIFFERENCE;

ADULT; AGED; BILIARY TRACT DISEASES; CONTRAST MEDIA; FEMALE; GADOLINIUM DTPA; HUMANS; LIVER DISEASES; LIVER FUNCTION TESTS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 80052144106     PISSN: 0720048X     EISSN: 18727727     Source Type: Journal    
DOI: 10.1016/j.ejrad.2010.03.008     Document Type: Article

References (17)

1. G. Schuhmann-Giampieri, H. Schmitt-Willich, and W.R. Press Preclinical evaluation of Gd-EOB-DTPA as a contrast agent in MR imaging of the hepatobiliary system Radiology 183 1 1992 59 64
2. B. Hamm, T. Staks, and A. Muhler Phase I clinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent: safety, pharmacokinetics, and MR imaging Radiology 195 3 1995 785 792
3. M. Bollow, M. Taupitz, and B. Hamm Gadolinium-ethoxybenzyl-DTPA as a hepatobiliary contrast agent for use in MR cholangiography: results of an in vivo phase-I clinical evaluation Eur Radiol 7 1 1997 126 132 (Pubitemid 127538537)
4. K. Holzapfel, C. Breitwieser, and C. Prinz Contrast-enhanced magnetic resonance cholangiography using gadolinium-EOB-DTPA, preliminary experience and clinical applications Radiologe 47 6 2007 536 544
5. J.E. van Montfoort, B. Stieger, and D.K. Meijer Hepatic uptake of the magnetic resonance imaging contrast agent gadoxetate by the organic anion transporting polypeptide Oatp1 J Pharmacol Exp Ther 290 1 1999 153 157 (Pubitemid 29302315)
6. H. Takao, H. Akai, and T. Tajima MR imaging of the biliary tract with Gd-EOB-DTPA: effect of liver function on signal intensity Eur J Radiol August 2009 [Epub ahead of print]
7. F.T. Tschirch, A. Struwe, and H. Petrowsky Contrast-enhanced MR cholangiography with Gd-EOB-DTPA in patients with liver cirrhosis: visualization of the biliary ducts in comparison with patients with normal liver parenchyma Eur Radiol 18 8 2008 1577 1586
8. J. Halavaara, J. Breuer, and C. Ayuso Liver tumor characterization: comparison between liver-specific gadoxetic acid disodium-enhanced MRI and biphasic CT - a multicenter trial J Comput Assist Tomogr 30 3 2006 345 354 (Pubitemid 43922248)
9. R. Hammerstingl, A. Huppertz, and J. Breuer Diagnostic efficacy of gadoxetic acid (Primovist)-enhanced MRI and spiral CT for a therapeutic strategy: comparison with intraoperative and histopathologic findings in focal liver lesions Eur Radiol 18 3 2008 457 467 (Pubitemid 351248177)
10. R.C. Carlos, H.K. Hussain, and J.H. Song Gadolinium-ethoxybenzyl- diethylenetriamine pentaacetic acid as an intrabiliary contrast agent: preliminary assessment AJR Am J Roentgenol 179 1 2002 87 92 (Pubitemid 34694816)
11. M.K. Lee, S. Kim, and J.W. Lee Biliary MR imaging with Gd-EOB-DTPA and its clinical applications Radiographics 29 2009 1707 1724
12. N. Dahlstrom, A. Persson, and N. Albiin Contrast-enhanced magnetic resonance cholangiography with Gd-BOPTA and Gd-EOB-DTPA in healthy subjects Acta Radiol 48 4 2007 362 368 (Pubitemid 46633865)
13. C. Koelblinger, W. Schima, and M. Weber Gadoxate-enhanced T 1-weighted MR cholangiography: comparison of 1.5 T and 3.0 T Rofo 181 6 2009 587 592
14. M. Seale, O. Catalano, and S. Saini Hepatobiliary-specific MR contrast agents: role in imaging the liver and biliary tree Radiology 29 2009 1725 1748
15. P. Pare, E.A. Shaffer, and L. Rosenthall Nonvisualization of the gallbladder by 99mTc-HIDA cholescintigraphy as evidence of cholecystitis Can Med Assoc J 118 4 1978 384 386 (Pubitemid 8312497)
16. A. Torsoli, E. Corazziari, and F.I. Habib Pressure relationships within the human bile tract. Normal and abnormal physiology Scand J Gastroenterol Suppl 175 1990 52 57 (Pubitemid 20276626)
17. W.J. Hogan, and J.E. Geenen Biliary dyskinesia Endoscopy 20 Suppl. 1 1988 179 183